Relmada Therapeutics
230
$48.219876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$48.21
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$3.20 (+7.11%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell RLMD and other stocks, options, ETFs, and crypto commission-free!
About RLMD
Relmada Therapeutics, Inc. Common Stock, also called Relmada Therapeutics, is a clinical-stage biotechnology company. Read More It engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases and other disorders. The company was founded on May 31, 2012 and is headquartered in New York, NY.
Employees
4
Headquarters
New York, New York
Founded
2012
Market Cap
732.70M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
140.50K
High Today
$49.00
Low Today
$42.24
Open Price
$45.00
Volume
270.91K
52 Week High
$52.22
52 Week Low
$22.40